Home
About
Services
Partners
Client Portfolio
News
Contact
0
Japan’s Takeda to sell some Asia-focused drugs to Celltrion for $278 million
Published by
Muller&Green
at
June 11, 2020
Categories
RSS
Tags
Takeda Pharmaceutical Co Ltd has agreed to sell a portfolio of over-the-counter and prescription drugs marketed in the Asia Pacific region to South Korea’s Celltrion Inc for $278 million, it said on Thursday
Powered by
WPeMatico
Muller&Green
Related posts
March 15, 2025
The Price of Gold Keeps Climbing. Here’s What to Know
Read more
March 14, 2025
American Airlines Plane Catches Fire at Denver Airport Gate
Read more
March 13, 2025
Why the U.S. Doesn’t Vaccinate Poultry Against Bird Flu
Read more
Exclusive: Pershing Square’s Ackman eyes $1 billion-plus ‘blank-check’ company – sources
June 11, 2020
Oil prices set for worst daily drop since April on inventories, bearish Fed
June 11, 2020